Stockreport

MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study

MediWound Ltd. - Ordinary Shares  (MDWD) 
Last mediwound ltd. - ordinary shares earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.mediwound.com/press-releases
PDF YAVNE, Israel, Feb. 12, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for tissue repair today ann [Read more]